Quantum Pharma (QP.) shed half its value as it warned in its half-year results that it would miss forecasts for this year by a "material" amount and is to shut Nupharm, a business acquired just a year ago.
IC TIP:
Hold
at
36p
It has been a torrid 12 months for Quantum which, after a strong debut on the Alternative Investment Market in early 2015, first showed signs of struggling in October last year. At that time, regulatory issues forced a delay in product launches - and eight months later both the chief executive and chief financial officer had jumped ship. Now Quantum is struggling to sell unbranded and medical device products and sales are therefore well behind targets.
